[HTML][HTML] Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: a systematic review and meta …
J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - journals.lww.com
Background: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …
Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in …
EO Murchu, L Comber, K Jordan… - Reviews in Medical …, 2023 - Wiley Online Library
The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …
Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in …
L Comber, K Jordan, S Hawkshaw… - Reviews in Medical …, 2022 - europepmc.org
The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database
M Pellegrini, U Nicolay, K Lindert, N Groth… - Vaccine, 2009 - Elsevier
BACKGROUND: Adding adjuvants such as MF59® to influenza vaccines can enhance the
immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+) MF59] …
immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+) MF59] …
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta …
BL Coleman, R Sanderson, MDM Haag… - Influenza and other …, 2021 - Wiley Online Library
Background Standard‐dose seasonal influenza vaccines often produce modest
immunogenic responses in adults≥ 65 years old. MF59 is intended to elicit a greater …
immunogenic responses in adults≥ 65 years old. MF59 is intended to elicit a greater …
[HTML][HTML] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis
A Domnich, L Arata, D Amicizia, J Puig-Barberà… - Vaccine, 2017 - Elsevier
Background In the elderly, traditional influenza inactivated vaccines are often only modestly
immunogenic, owing to immunosenescence. Given that adjuvantation is a means of …
immunogenic, owing to immunosenescence. Given that adjuvantation is a means of …
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …
G Della Cioppa, U Nicolay, K Lindert… - Human vaccines & …, 2014 - Taylor & Francis
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …
[HTML][HTML] Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysis
A Domnich, C de Waure - International Journal of Infectious Diseases, 2022 - Elsevier
Objectives MF59-adjuvanted standard-dose and nonadjuvanted high-dose seasonal
influenza vaccines have been developed to protect the elderly at high risk of severe …
influenza vaccines have been developed to protect the elderly at high risk of severe …
MF59™-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations
J Puig Barberà, D González Vidal - Expert review of vaccines, 2007 - Taylor & Francis
Influenza is a highly contagious respiratory disease associated with substantial morbidity
and mortality in vulnerable populations, especially the elderly. Influenza viruses are unique …
and mortality in vulnerable populations, especially the elderly. Influenza viruses are unique …
Relative effectiveness of MF59 adjuvanted trivalent influenza vaccine vs nonadjuvanted vaccines during the 2019–2020 influenza season
M Imran, J Puig-Barbera, JR Ortiz… - Open forum …, 2022 - academic.oup.com
Background Age-related immunosenescence may impair the immune response to
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …
vaccination in older adults. Adjuvanted influenza vaccines are designed to overcome …